SOUTH SAN FRANCISCO, Feb. 5, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on advancing cancer care, announced today that Steven R. Deitcher, M.D., President & Chief Executive Officer, will present a company update at the 10th Annual BIO CEO & Investor Conference on Tuesday, February 12th at 9:30 a.m. ET in the Beekman Suite at the Waldorf Astoria in New York, NY.
